HomeBUSINESS
BUSINESS

Eisai CEO Sees 4 Global Brands as Drivers through FY2020
(Nov.2.2017)

Eisai CEO Haruo Naito
Eisai CEO Haruo Naito voiced his expectations on November 1 for four global brands - Lenvima (lenvatinib), Halaven (eribulin), Fycompa (perampanel), and Belviq (lorcaserin) - as growth engines to drive the company’s business through FY2020 ...
(LOG IN FOR FULL STORY)

News Calendar